Überla K - Search Results

1

Oriented display of HIV-1 Env trimers by a novel coupling strategy enhances B cell activation and phagocytosis.

Di Vincenzo R, Beutel J, Arnold P, Wang Y, Damm D, Tannig P, Lux A, Temchura V, Eichler J, Überla K. Di Vincenzo R, et al. Among authors: uberla k. Front Immunol. 2024 Feb 8;15:1344346. doi: 10.3389/fimmu.2024.1344346. eCollection 2024. Front Immunol. 2024. PMID: 38390320 Free PMC article.

2

Antigen-dependent modulation of immune responses to antigen-Fc fusion proteins by Fc-effector functions.

Richel E, Wagner JT, Klessing S, Di Vincenzo R, Temchura V, Überla K. Richel E, et al. Among authors: uberla k. Front Immunol. 2023 Oct 5;14:1275193. doi: 10.3389/fimmu.2023.1275193. eCollection 2023. Front Immunol. 2023. PMID: 37868961 Free PMC article.

3

Modulation of immune responses to liposomal vaccines by intrastructural help.

Damm D, Suleiman E, Wagner JT, Klessing S, Pfister F, Elsayed H, Walkenfort B, Stobrawe J, Mayer J, Lehner E, Müller-Schmucker SM, Hasenberg M, Wyatt RT, Vorauer-Uhl K, Temchura V, Überla K. Damm D, et al. Among authors: uberla k. Eur J Pharm Biopharm. 2023 Nov;192:112-125. doi: 10.1016/j.ejpb.2023.10.003. Epub 2023 Oct 4. Eur J Pharm Biopharm. 2023. PMID: 37797679 Free PMC article.

4

Population-based study of the durability of humoral immunity after SARS-CoV-2 infection.

Peterhoff D, Wiegrebe S, Einhauser S, Patt AJ, Beileke S, Günther F, Steininger P, Niller HH, Burkhardt R, Küchenhoff H, Gefeller O, Überla K, Heid IM, Wagner R. Peterhoff D, et al. Among authors: uberla k. Front Immunol. 2023 Oct 5;14:1242536. doi: 10.3389/fimmu.2023.1242536. eCollection 2023. Front Immunol. 2023. PMID: 37868969 Free PMC article.

5

Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults.

Prelog M, Jeske SD, Asam C, Fuchs A, Wieser A, Gall C, Wytopil M, Mueller-Schmucker SM, Beileke S, Goekkaya M, Kling E, Geldmacher C, Rubio-Acero R, Plank M, Christa C, Willmann A, Vu M, Einhauser S, Weps M, Lampl BMJ, Almanzar G, Kousha K, Schwägerl V, Liebl B, Weber B, Drescher J, Scheidt J, Gefeller O, Messmann H, Protzer U, Liese J, Hoelscher M, Wagner R, Überla K, Steininger P; CoVaKo Study Group. Prelog M, et al. Among authors: uberla k. J Clin Virol. 2024 Feb;170:105622. doi: 10.1016/j.jcv.2023.105622. Epub 2023 Nov 28. J Clin Virol. 2024. PMID: 38091664

6

Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens: a comparative observational cohort study.

Warkentin L, Werner F, Zeschick N, Kühlein T, Steininger P, Überla K, Kaiser I, Sebastião M, Hueber S. Warkentin L, et al. Among authors: uberla k. BMC Med. 2023 Jun 20;21(1):218. doi: 10.1186/s12916-023-02924-5. BMC Med. 2023. PMID: 37340463 Free PMC article.

7

Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study.

Werner F, Zeschick N, Kühlein T, Steininger P, Überla K, Kaiser I, Sebastião M, Hueber S, Warkentin L. Werner F, et al. Among authors: uberla k. BMC Med. 2023 Sep 19;21(1):358. doi: 10.1186/s12916-023-03064-6. BMC Med. 2023. PMID: 37726711 Free PMC article.

8

HIV-1 neutralizing antibodies provide sterilizing immunity by blocking infection of the first cells.

Stab V, Stahl-Hennig C, Ensser A, Richel E, Fraedrich K, Sauermann U, Tippler B, Klein F, Burton DR, Tenbusch M, Überla K. Stab V, et al. Among authors: uberla k. Cell Rep Med. 2023 Oct 17;4(10):101201. doi: 10.1016/j.xcrm.2023.101201. Epub 2023 Oct 6. Cell Rep Med. 2023. PMID: 37804829 Free PMC article.

9

Bind&Bite: covalently stabilized heterodimeric coiled-coil peptides for the site-selective, cysteine-free chemical modification of proteins.

Beutel J, Tannig P, Di Vincenzo R, Schumacher T, Überla K, Eichler J. Beutel J, et al. Among authors: uberla k. RSC Chem Biol. 2023 Aug 8;4(10):794-803. doi: 10.1039/d3cb00122a. eCollection 2023 Oct 4. RSC Chem Biol. 2023. PMID: 37799587 Free PMC article.

10

A second update on mapping the human genetic architecture of COVID-19.

COVID-19 Host Genetics Initiative. COVID-19 Host Genetics Initiative. Nature. 2023 Sep;621(7977):E7-E26. doi: 10.1038/s41586-023-06355-3. Epub 2023 Sep 6. Nature. 2023. PMID: 37674002 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

289 results

Search Page